X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs PANACEA BIOTECH - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD PANACEA BIOTECH MERCK LTD/
PANACEA BIOTECH
 
P/E (TTM) x 33.5 159.0 21.1% View Chart
P/BV x 3.7 3.5 106.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 MERCK LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    MERCK LTD
Dec-16
PANACEA BIOTECH
Mar-14
MERCK LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,060149 712.8%   
Low Rs62382 757.0%   
Sales per share (Unadj.) Rs632.484.1 751.6%  
Earnings per share (Unadj.) Rs45.7-18.3 -249.7%  
Cash flow per share (Unadj.) Rs62.3-6.7 -930.2%  
Dividends per share (Unadj.) Rs11.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs388.883.7 464.5%  
Shares outstanding (eoy) m16.6061.25 27.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.4 96.9%   
Avg P/E ratio x18.4-6.3 -291.8%  
P/CF ratio (eoy) x13.5-17.2 -78.3%  
Price / Book Value ratio x2.21.4 156.9%  
Dividend payout %24.10-   
Avg Mkt Cap Rs m13,9697,074 197.5%   
No. of employees `0001.62.8 57.6%   
Total wages/salary Rs m1,4871,449 102.6%   
Avg. sales/employee Rs Th6,631.91,874.1 353.9%   
Avg. wages/employee Rs Th939.2527.0 178.2%   
Avg. net profit/employee Rs Th479.4-407.7 -117.6%   
INCOME DATA
Net Sales Rs m10,4985,154 203.7%  
Other income Rs m242100 242.9%   
Total revenues Rs m10,7415,254 204.4%   
Gross profit Rs m1,135-766 -148.2%  
Depreciation Rs m276711 38.7%   
Interest Rs m01,503 0.0%   
Profit before tax Rs m1,102-2,881 -38.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m34317 2,043.5%   
Profit after tax Rs m759-1,121 -67.7%  
Gross profit margin %10.8-14.9 -72.7%  
Effective tax rate %31.1-0.6 -5,340.4%   
Net profit margin %7.2-21.8 -33.2%  
BALANCE SHEET DATA
Current assets Rs m6,4103,810 168.2%   
Current liabilities Rs m8,8288,365 105.5%   
Net working cap to sales %-23.0-88.4 26.1%  
Current ratio x0.70.5 159.4%  
Inventory Days Days58156 37.0%  
Debtors Days Days3867 57.1%  
Net fixed assets Rs m1,40614,480 9.7%   
Share capital Rs m16661 270.8%   
"Free" reserves Rs m6,286903 696.0%   
Net worth Rs m6,4555,127 125.9%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m8,82819,433 45.4%  
Interest coverage xNM-0.9-  
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x1.20.3 448.4%   
Return on assets %8.62.0 437.7%  
Return on equity %11.8-21.9 -53.8%  
Return on capital %17.13.6 469.6%  
Exports to sales %8.324.5 33.8%   
Imports to sales %21.010.2 206.7%   
Exports (fob) Rs m8691,264 68.8%   
Imports (cif) Rs m2,209525 421.0%   
Fx inflow Rs m9591,539 62.3%   
Fx outflow Rs m2,612942 277.3%   
Net fx Rs m-1,653597 -276.8%   
CASH FLOW
From Operations Rs m1,070599 178.6%  
From Investments Rs m-750-438 171.2%  
From Financial Activity Rs m-150-303 49.5%  
Net Cashflow Rs m171-141 -120.9%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.6 3,033.3%  
FIIs % 1.0 1.3 76.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 23.6 123.3%  
Shareholders   28,591 10,259 278.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare MERCK LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Sensex Touching New Highs, Takeaways from Acquisition of HPCL and Top Stocks in Action Today(Pre-Open)

BSE Sensex is on a roll. The index touched a record high of 35,798 yesterday. Considering a span of one year, the benchmark index has delivered a 32% return.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 23, 2018 09:25 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS